ALKS Samuel Joseph Parisi sells $132K worth of shares
Feb 26, 2025, 5:33 AM
-1.94%
What does ALKS do
Alkermes Plc is a biopharmaceutical company based in Dublin, focused on developing treatments for alcohol and opioid dependence, schizophrenia, and bipolar I disorder, employing 2,100 people. Its key products include LYBALVI, ARISTADA, and VIVITROL, with ongoing development for neurological disorders and cancer.
Samuel Joseph Parisi sold 3,743 shares of ALKS on 25 February at $35.26 per share, worth a total of $132K. They now own 7,717 ALKS shares, or a 33% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
